Scribd
Upload
44 views9 pages

Vision Report With Sources

The document highlights the critical economic impact of vision impairment and blindness, estimating a cumulative GNI loss of ₹11.8 trillion over 20 years in India. It emphasizes the importance of regular eye examinations and preventive measures to combat common eye conditions, which affect millions globally. Additionally, it addresses the rising issue of digital eye strain due to increased screen time, urging individuals to adopt daily habits for optimal eye health.

Uploaded by

aaravgodara24
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
44 views9 pages

Vision Report With Sources

The document highlights the critical economic impact of vision impairment and blindness, estimating a cumulative GNI loss of ₹11.8 trillion over 20 years in India. It emphasizes the importance of regular eye examinations and preventive measures to combat common eye conditions, which affect millions globally. Additionally, it addresses the rising issue of digital eye strain due to increased screen time, urging individuals to adopt daily habits for optimal eye health.

Uploaded by

aaravgodara24
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

The Critical Role of Eyecare:

Protecting Vision
💸 Annual GNI loss due to blindness: ₹845 billion
👤 Per blind person loss: ₹1.7 lakh
📈 Cumulative GNI loss (20 years): ₹11.8 trillion
📉 Productivity loss from vision impairment: ₹646
billion
⚠️ Loss has tripled in two decades
The Global & Indian Crisis

India's Challenge
Global Impact

Over 1 billion cases of Affected: 270 million


vision impairment visually impaired, 9–
can be prevented. 11 million blind.

Affected: 2.2 billion Registered: ~12


visually impaired, million blind/partially
39 million blind. sighted.
Economic Cost: Economic Cost: ₹1.2–1.5
Over $411 billion lakh crore (approx. $15–
USD annually.
18 billion USD) annually.
Common Eye Conditions and Their
Impact
Cataracts 12 million+ affected ~94 million globally

Glaucoma ~12 million cases ~80 million (projected 112M by 2040)

AMD 3–4 million estimated ~200 million affected

Diabetic Retinopathy 1 in 5 diabetics ~146 million globally


~2.6 billion globally (projected ~50%
Myopia ~35% of urban children
by 2050)
Identifying Key Risk Factors for Vision
Loss

Age Genetics Systemic Health


Increased risk for cataracts, Family history increases Diabetes, high blood pressure,
glaucoma, AMD after 40. glaucoma risk by 4x. autoimmune diseases.

Lifestyle Environment
Smoking increases AMD Prolonged screen use, poor
risk by 3x; excessive UV lighting conditions.
exposure.
The Power of Prevention: Regular Eye
Examinations

Early Detection: 80–90% of serious eye conditions detectable early.


Adults: Check-ups every 1–2 years after 40.
Children: School screenings catch issues like amblyopia.
Health Links: Reveal diabetes, hypertension, brain disorders.
Free Care: Government provides free screenings and surgery.
Daily Habits for Optimal Eye
Health
UV Protection
Wear 100% UV-blocking sunglasses outdoors.

Eye Breaks
Apply the 20-20-20 rule: Every 20 mins, look 20 feet away for 20 seconds.

Hygiene
Wash hands, replace contact lenses regularly.

Safety Eyewear
Protect eyes during DIY, sports, or hazardous work.

Hydration
Drink 8 glasses of water daily to prevent dry eyes.
The Digital Age: Tackling Digital Eye
Strain
Digital eye strain affects ~50–60% of adults using digital devices regularly.

Symptoms: Dry eyes, blurred vision, headaches, neck pain.

Factors: Blue light emission, reduced blink rate, screen glare.

Solutions: Anti-glare screens, ergonomic setup, blinking exercises, blue light


filters.
Our Source
Conclusion: Prioritise Your Precious
Sight

Prevention is Key Regular Eye Exams Daily Habits

New Technologies
Sources
Slide 1: WHO – World Report on Vision
[Link]
Slide 2: RNIB & Birmingham Public Health
[Link]
[Link]
Slide 3: NPCB, IJO, Seva & Orbis
[Link]
[Link]
[Link]
[Link]
Slide 4: The Lancet Global Health
[Link]
Slide 5: WHO & IAPB
[Link]
Slide 6: AAO & WHO Risk Sheet
[Link]
[Link]
Slide 7: CDC & NEI
[Link]
[Link]
Slide 8: AOA & Harvard Health
[Link]
[Link]

You might also like